The United States will share COVID-19 vaccines from AstraZeneca with the rest of the world once it passes federal safety expectations, according to The Associated Press.
Around 60 million doses of the company’s vaccine are expected to be exported globally, the White House told the AP.
“Given the strong portfolio of vaccines that the U.S. already has and that have been authorized by the FDA, and given that the AstraZeneca vaccine is not authorized for use in the U.S., we do not need to use the AstraZeneca vaccine here during the next several months,” White House COVID-19 coordinator Jeff Zients told the AP. “Therefore the U.S. is looking at options to share the AstraZeneca doses with other countries as they become available.”
In March, the Biden administration provided 4 million doses of the AstraZeneca COVID-19 vaccine to Mexico and Canada.
Over 53% of adults in the U.S. have received at least one dose of the three available vaccines from Pfizer, Moderna and Johnson & Johnson.
The AstraZeneca vaccine was not approved yet by the FDA, as it has not filed for an emergency-use authorization, according to reports.